190 related articles for article (PubMed ID: 11773031)
1. The role of Langerhans cells in Pseudomonas aeruginosa infection.
Hazlett LD; McClellan SA; Rudner XL; Barrett RP
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):189-97. PubMed ID: 11773031
[TBL] [Abstract][Full Text] [Related]
2. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive.
Hazlett LD; McClellan S; Kwon B; Barrett R
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):805-10. PubMed ID: 10711697
[TBL] [Abstract][Full Text] [Related]
3. B7/CD28 costimulation is critical in susceptibility to Pseudomonas aeruginosa corneal infection: a comparative study using monoclonal antibody blockade and CD28-deficient mice.
Hazlett LD; McClellan S; Barrett R; Rudner X
J Immunol; 2001 Jan; 166(2):1292-9. PubMed ID: 11145712
[TBL] [Abstract][Full Text] [Related]
4. Further studies on the role of IL-12 in Pseudomonas aeruginosa corneal infection.
Hazlett LD; Huang X; McClellan SA; Barrett RP
Eye (Lond); 2003 Nov; 17(8):863-71. PubMed ID: 14631390
[TBL] [Abstract][Full Text] [Related]
5. Role of IL-12 and IFN-gamma in Pseudomonas aeruginosa corneal infection.
Hazlett LD; Rudner XL; McClellan SA; Barrett RP; Lighvani S
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):419-24. PubMed ID: 11818386
[TBL] [Abstract][Full Text] [Related]
6. ST2 is essential for Th2 responsiveness and resistance to pseudomonas aeruginosa keratitis.
Huang X; Du W; Barrett RP; Hazlett LD
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4626-33. PubMed ID: 17898286
[TBL] [Abstract][Full Text] [Related]
7. TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis.
Huang X; Du W; McClellan SA; Barrett RP; Hazlett LD
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4910-6. PubMed ID: 17065506
[TBL] [Abstract][Full Text] [Related]
8. Corneal response to Pseudomonas aeruginosa infection.
Hazlett LD
Prog Retin Eye Res; 2004 Jan; 23(1):1-30. PubMed ID: 14766315
[TBL] [Abstract][Full Text] [Related]
9. Substance P promotes susceptibility to Pseudomonas aeruginosa keratitis in resistant mice: anti-inflammatory mediators downregulated.
McClellan SA; Zhang Y; Barrett RP; Hazlett LD
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1502-11. PubMed ID: 18385069
[TBL] [Abstract][Full Text] [Related]
10. Silencing Toll-like receptor-9 in Pseudomonas aeruginosa keratitis.
Huang X; Barrett RP; McClellan SA; Hazlett LD
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4209-16. PubMed ID: 16249500
[TBL] [Abstract][Full Text] [Related]
11. Macrophages restrict Pseudomonas aeruginosa growth, regulate polymorphonuclear neutrophil influx, and balance pro- and anti-inflammatory cytokines in BALB/c mice.
McClellan SA; Huang X; Barrett RP; van Rooijen N; Hazlett LD
J Immunol; 2003 May; 170(10):5219-27. PubMed ID: 12734370
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-9 amplifies the immune response to Pseudomonas aeruginosa corneal infection.
McClellan SA; Huang X; Barrett RP; Lighvani S; Zhang Y; Richiert D; Hazlett LD
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):256-64. PubMed ID: 16384971
[TBL] [Abstract][Full Text] [Related]
13. Role of innate and adaptive immunity in the pathogenesis of keratitis.
Hazlett LD
Ocul Immunol Inflamm; 2005; 13(2-3):133-8. PubMed ID: 16019672
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic mechanisms of P. aeruginosa keratitis: a review of the role of T cells, Langerhans cells, PMN, and cytokines.
Hazlett LD
DNA Cell Biol; 2002; 21(5-6):383-90. PubMed ID: 12167240
[TBL] [Abstract][Full Text] [Related]
15. Substance P regulates natural killer cell interferon-gamma production and resistance to Pseudomonas aeruginosa infection.
Lighvani S; Huang X; Trivedi PP; Swanborg RH; Hazlett LD
Eur J Immunol; 2005 May; 35(5):1567-75. PubMed ID: 15832292
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Pseudomonas aeruginosa corneal infection using an oligonucleotide microarray.
Huang X; Hazlett LD
Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3409-16. PubMed ID: 12882789
[TBL] [Abstract][Full Text] [Related]
17. Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection.
Hazlett LD; McClellan SA; Barrett RP; Liu J; Zhang Y; Lighvani S
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):797-807. PubMed ID: 17251480
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 17 regulates Mer tyrosine kinase-positive cells in Pseudomonas aeruginosa keratitis.
Li C; McClellan SA; Barrett R; Hazlett LD
Invest Ophthalmol Vis Sci; 2014 Oct; 55(10):6886-900. PubMed ID: 25298414
[TBL] [Abstract][Full Text] [Related]
19. Macrophage inflammatory protein-2 is a mediator of polymorphonuclear neutrophil influx in ocular bacterial infection.
Kernacki KA; Barrett RP; Hobden JA; Hazlett LD
J Immunol; 2000 Jan; 164(2):1037-45. PubMed ID: 10623854
[TBL] [Abstract][Full Text] [Related]
20. High-mobility group box 1: a novel target for treatment of Pseudomonas aeruginosa keratitis.
McClellan S; Jiang X; Barrett R; Hazlett LD
J Immunol; 2015 Feb; 194(4):1776-87. PubMed ID: 25589066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
